Atenolol/Chlorthalidone

阿替洛尔/氯噻酮

Report date: 2026/04/25 20:00:23

Base Information

Drug NameAtenolol/Chlorthalidone
Drug Alias NameAtenolol•Chlorthalidone氯噻酮•阿替洛尔氯噻酮/阿替洛尔Chlorthalidone•Atenolol阿替洛尔氯噻酮 +[12] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterVoltage-gated calcium channelAdrenergic receptors
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/06/08
Country/TerritoryUnited States
CombinationsYes AtenololChlorthalidone
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTwi Pharmaceuticals IncAtnahs Pharma Uk Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC07CB03
Related LinksWikipediaKEGG